Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ropidoxuridine with whole brain radiation therapy for brain metastases; status is ACTIVE_NOT_RECRUITING with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropidoxuridine (ropidoxuridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-02-20